Acadia Pharmaceuticals
ACAD
ACAD
193 hedge funds and large institutions have $3.17B invested in Acadia Pharmaceuticals in 2015 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 65 increasing their positions, 63 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
193
Holders Change
+11
Holders Change %
+6.04%
% of All Funds
5.15%
Holding in Top 10
4
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-50%
% of All Funds
0.11%
New
35
Increased
65
Reduced
63
Closed
23
Calls
$45.7M
Puts
$32.2M
Net Calls
+$13.6M
Net Calls Change
-$59.5M
Top Buyers
| 1 |
O
OppenheimerFunds
New York
|
+$121M |
| 2 |
Capital World Investors
Los Angeles,
California
|
+$68.7M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$40M |
| 4 |
Franklin Resources
San Mateo,
California
|
+$24.6M |
| 5 |
HM
HealthCor Management
New York
|
+$23.6M |
Top Sellers
| 1 |
Viking Global Investors
Stamford,
Connecticut
|
-$93.9M |
| 2 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$44.2M |
| 3 |
Alkeon Capital Management
New York
|
-$41M |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$29.5M |
| 5 |
Bank of New York Mellon
New York
|
-$24.2M |
